Gower A - Search Results

1

Novel ALK Fusion, PPFIBP1-ALK, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and Lorlatinib.

Gower A, Golestany B, Gong J, Singhi AD, Hendifar AE. Gower A, et al. JCO Precis Oncol. 2020 Jul 27;4:PO.19.00365. doi: 10.1200/PO.19.00365. eCollection 2020. JCO Precis Oncol. 2020. PMID: 32923899 Free PMC article. No abstract available.

2

Three Primary Tumors Including EGFR-mutated Non-Small Cell Lung Cancer as First Presentation in Patient With Li-Fraumeni Syndrome.

Gower A, Kim J, Spector K, Menashe D, Vail E, Natale R. Gower A, et al. Clin Lung Cancer. 2021 Jan;22(1):e116-e121. doi: 10.1016/j.cllc.2020.09.006. Epub 2020 Sep 18. Clin Lung Cancer. 2021. PMID: 33172777 No abstract available.

3

Pembrolizumab in advanced non-small cell lung cancer: safety implications of dose adjustments.

Gower A, Garon EB. Gower A, et al. Transl Cancer Res. 2022 Dec;11(12):4479-4481. doi: 10.21037/tcr-22-2429. Transl Cancer Res. 2022. PMID: 36644181 Free PMC article. No abstract available.

4

Targeting more precisely: Improving sensitivity to EGFR inhibitors in NSCLC.

Gower A, Garon EB. Gower A, et al. Med. 2021 Nov 12;2(11):1201-1202. doi: 10.1016/j.medj.2021.10.005. Med. 2021. PMID: 35590196 Free article.

5

EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer.

Gower A, Hsu WH, Hsu ST, Wang Y, Giaccone G. Gower A, et al. Mol Oncol. 2016 Apr;10(4):601-9. doi: 10.1016/j.molonc.2015.11.007. Epub 2015 Nov 24. Mol Oncol. 2016. PMID: 26639656 Free PMC article.

6

Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer.

Gower A, Wang Y, Giaccone G. Gower A, et al. J Mol Med (Berl). 2014 Jul;92(7):697-707. doi: 10.1007/s00109-014-1165-y. Epub 2014 May 23. J Mol Med (Berl). 2014. PMID: 24852181 Free PMC article. Review.

7

CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma.

An R, Wang Y, Voeller D, Gower A, Kim IK, Zhang YW, Giaccone G. An R, et al. Among authors: gower a. Oncotarget. 2016 May 17;7(20):29199-210. doi: 10.18632/oncotarget.8638. Oncotarget. 2016. PMID: 27078848 Free PMC article.

8

Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples.

Wilson TR, Xiao Y, Spoerke JM, Fridlyand J, Koeppen H, Fuentes E, Huw LY, Abbas I, Gower A, Schleifman EB, Desai R, Fu L, Sumiyoshi T, O'Shaughnessy JA, Hampton GM, Lackner MR. Wilson TR, et al. Among authors: gower a. Breast Cancer Res Treat. 2014 Nov;148(2):315-25. doi: 10.1007/s10549-014-3163-8. Epub 2014 Oct 22. Breast Cancer Res Treat. 2014. PMID: 25338319 Free PMC article.

9

Effectiveness of Single-Fraction, Low-Dose, Bilateral Whole Lung Radiation Therapy for Diffuse Alveolar Hemorrhage Secondary to Extramedullary Hematopoiesis: A Case Report and Review of the Literature.

Neilsen BK, Sleightholm RL, Gower A, Tsai SC, Schiller GJ, Oliai C, Lee A, Raldow A, Tenn S, Venkat PS. Neilsen BK, et al. Among authors: gower a. Adv Radiat Oncol. 2024 Apr 10;9(7):101506. doi: 10.1016/j.adro.2024.101506. eCollection 2024 Jul. Adv Radiat Oncol. 2024. PMID: 38799111 Free PMC article. No abstract available.

10

Alleviating iatrogenic effects of paclitaxel via antiinflammatory treatment.

Zhang M, Lotfollahzadeh S, Elzinad N, Yang X, Elsadawi M, Gower AC, Belghasem M, Shazly T, Kolachalama VB, Chitalia VC. Zhang M, et al. Among authors: gower ac. Vasc Med. 2024 Apr 16:1358863X241231942. doi: 10.1177/1358863X241231942. Online ahead of print. Vasc Med. 2024. PMID: 38623630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page